Cunjie Chang

Hangzhou, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications

N6-Methyladenosine-Modified circNEK11 Promotes Hepatocellular Carcinoma Progression via the miR-1236-3p/GPX2 Axis.

N6-Methyladenosine-Modified circNEK11 Promotes Hepatocellular Carcinoma Progression via the miR-1236-3p/GPX2 Axis.

Journal: Cancer science
Published: February 20, 2025

Redistribution of super-enhancers promotes malignancy in human hepatocellular carcinoma.

Redistribution of super-enhancers promotes malignancy in human hepatocellular carcinoma.

Journal: Journal of advanced research
Published: September 14, 2024

Intron Retention of DDX39A Driven by SNRPD2 is a Crucial Splicing Axis for Oncogenic MYC/Spliceosome Program in Hepatocellular Carcinoma.

Intron Retention of DDX39A Driven by SNRPD2 is a Crucial Splicing Axis for Oncogenic MYC/Spliceosome Program in Hepatocellular Carcinoma.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: April 01, 2024

Kinesin family member 18B activates mTORC1 signaling via actin gamma 1 to promote the recurrence of human hepatocellular carcinoma.

Kinesin family member 18B activates mTORC1 signaling via actin gamma 1 to promote the recurrence of human hepatocellular carcinoma.

Journal: Oncogenesis
Published: February 20, 2023

The aberrant upregulation of exon 10-inclusive SREK1 through SRSF10 acts as an oncogenic driver in human hepatocellular carcinoma.

The aberrant upregulation of exon 10-inclusive SREK1 through SRSF10 acts as an oncogenic driver in human hepatocellular carcinoma.

Journal: Nature communications
Published: February 22, 2021

USP5 facilitates non-small cell lung cancer progression through stabilization of PD-L1.

USP5 facilitates non-small cell lung cancer progression through stabilization of PD-L1.

Journal: Cell death & disease
Published: February 19, 2021

Dysregulation of Wnt/β-catenin signaling by protein kinases in hepatocellular carcinoma and its therapeutic application.

Dysregulation of Wnt/β-catenin signaling by protein kinases in hepatocellular carcinoma and its therapeutic application.

Journal: Cancer science
Published: December 09, 2020

Salmonella flagella confer anti-tumor immunological effect via activating Flagellin/TLR5 signalling within tumor microenvironment.

Salmonella flagella confer anti-tumor immunological effect via activating Flagellin/TLR5 signalling within tumor microenvironment.

Journal: Acta pharmaceutica Sinica. B
Published: December 09, 2020

Erianin inhibits the oncogenic properties of hepatocellular carcinoma via inducing DNA damage and aberrant mitosis.

Erianin inhibits the oncogenic properties of hepatocellular carcinoma via inducing DNA damage and aberrant mitosis.

Journal: Biochemical pharmacology
Published: August 10, 2020

Honokiol inhibits bladder tumor growth by suppressing EZH2/miR-143 axis.

Honokiol inhibits bladder tumor growth by suppressing EZH2/miR-143 axis.

Journal: Oncotarget
Published: March 22, 2015

GOLPH3 is a potential therapeutic target and a prognostic indicator of poor survival in bladder cancer treated by cystectomy.

GOLPH3 is a potential therapeutic target and a prognostic indicator of poor survival in bladder cancer treated by cystectomy.

Journal: Oncotarget
Published: March 16, 2015

Truncated ERG Oncoproteins from TMPRSS2-ERG Fusions Are Resistant to SPOP-Mediated Proteasome Degradation.

Truncated ERG Oncoproteins from TMPRSS2-ERG Fusions Are Resistant to SPOP-Mediated Proteasome Degradation.

Journal: Molecular cell
Published: March 03, 2015
Showing 1-12 of 21

Last Updated: 09/26/2026